BDR Pharmaceuticals Gets CDSCO Panel Nod for bioequvalence study of Abiraterone Acetate Oral Suspension Dr. Divya Colin25 Dec 2024 6:15 PM ISTNew Delhi: BDR Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
MSN Laboratories gets CDSCO Panel nod to conduct Bioequivalence Study of Abiraterone Tablets1000mg Dr. Divya Colin18 Aug 2024 5:45 PM ISTNew Delhi: MSN Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
BDR Pharmaceuticals gets CDSCO panel nod to manufacture, market anticancer drug Abiraterone Acetate Oral Suspension Dr. Divya Colin8 Jun 2024 10:07 PM ISTNew Delhi: In a significant development, BDR Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Conduct Phase III clinical trial: CDSCO Panel Tells BDR Pharmaceutical on Anti-cancer Drug Abiraterone Acetate Dr. Divya Colin20 April 2024 5:45 PM ISTNew Delhi: Reviewing the justification for waiver of the Phase III clinical trial of the anti-cancer drug Abiraterone Acetate presented by BDR...
Janssen bags USFDA nod for Akeega to treat prostate cancer Ruchika Sharma12 Aug 2023 11:35 AM ISTHorsham: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food & Drug Administration (FDA) has...
Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations Ruchika Sharma22 April 2023 11:32 AM ISTThe EC authorisation, which also marks the first worldwide approval for AKEEGA, is based on results of the randomised, double-blind, placebo...
Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations Ruchika Sharma2 March 2023 3:15 PM ISTMetastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...
Metformin and statins improve overall survival in men with castration-resistant metastatic prostate cancer: Study Medha Baranwal10 Jun 2022 8:00 PM ISTCanada: The use of metformin and statins results in prolonged overall survival and an improved response rate of prostate-specific antigen (PSA),...
Add-on abiraterone has survival benefit in high-risk prostate cancer: Study Dr. Shravani Dali7 Feb 2022 9:00 AM ISTAdd-on abiraterone has survival benefits in high-risk prostate cancer, according to a recent study published in the Lancet. Men with high-risk...
Abiraterone acetate helps with better quality of life than Docetaxel in Prostate Cancer: ASCO Medical Dialogues Editorial Team4 Jan 2022 9:00 AM ISTIn a new research done by Hannah L Rush and colleagues, it was shown that during a 2-year period, patient-reported QOL was superior for patients...
New formulation dramatically improves quality of life in prostate cancer Dr. Kamal Kant Kohli22 Jun 2020 6:30 PM ISTResearchers at University of South Australia have found that a novel formulation of prostate cancer drug abiraterone acetate - currently marketed as...
